Sarcoma

Gemcitabine maintenance therapy shows potential in metastasized STS

Patients with aggressive metastasized soft tissue sarcomas (STS) may benefit from gemcitabine maintenance therapy after docetaxel and gemcitabine chemotherapy, according to a study that encourages prospective trials evaluating gemcitabine maintenance. Patients who had undergone salvage chemotherapy with docetaxel and demcitabine, including one with leiomyosarcoma of the pancreas (patient 1), one...